BioSig Technologies, Inc.
  • Home
  • About BioSig
    • Overview
    • Leadership
    • Partnerships
  • PURE EP
    • Our Solution
    • Publications
    • Physician Insights
  • Join Our Team
  • News & Media
    • Overview
    • Press Releases
    • BioSig in the News
    • Presentations
    • Events
    • Newsletter
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
Investors

Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Fact Sheet
    • Contacts
    • RSS News Feed

Press Releases

  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence

August 24, 2022

BioSig’s Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022

August 17, 2022

BioSig Sees Positive Momentum from Sales Pipeline Growth

August 16, 2022

BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute

July 21, 2022

BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center

July 7, 2022

BioSig Announces Closing of Public Offering of Common Stock

June 29, 2022

BioSig Announces Pricing of Public Offering of Common Stock

June 24, 2022

BioSig Announces Proposed Public Offering of Common Stock

June 23, 2022

BioSig Announces New Evaluation Agreement for its PURE EP System with Cleveland Clinic

June 22, 2022

BioSig Advances its PURE™ System Commercial Launch to Medical Centers Nationwide

May 26, 2022
rss_feed News RSS
  • Previous
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...32
    Next
    Award
    BioSig Technologies, Inc.
    Sign Up for BioSig Updates Contact Us
    Twitter linkedin Facebook
    © 2023 BioSig Technologies, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap